These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9878198)

  • 21. CGP 56999A, a GABA(B) receptor antagonist, enhances expression of brain-derived neurotrophic factor and attenuates dopamine depletion in the rat corpus striatum following a 6-hydroxydopamine lesion of the nigrostriatal pathway.
    Enna SJ; Reisman SA; Stanford JA
    Neurosci Lett; 2006 Oct; 406(1-2):102-6. PubMed ID: 16890350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relative vulnerability of dopamine and GABA neurons in mesencephalic culture to inhibition of succinate dehydrogenase by malonate and 3-nitropropionic acid and protection by NMDA receptor blockade.
    Zeevalk GD; Derr-Yellin E; Nicklas WJ
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1124-30. PubMed ID: 8531072
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Melatonin protects against neuronal damage induced by 3-nitropropionic acid in rat striatum.
    Nam E; Lee SM; Koh SE; Joo WS; Maeng S; Im HI; Kim YS
    Brain Res; 2005 Jun; 1046(1-2):90-6. PubMed ID: 15882841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 17 beta-Estradiol may affect vulnerability of striatum in a 3-nitropropionic acid-induced experimental model of Huntington's disease in ovariectomized rats.
    Túnez I; Collado JA; Medina FJ; Peña J; Del C Muñoz M; Jimena I; Franco F; Rueda I; Feijóo M; Muntané J; Montilla P
    Neurochem Int; 2006 Apr; 48(5):367-73. PubMed ID: 16420966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mitochondrial stress-induced dopamine efflux and neuronal damage by malonate involves the dopamine transporter.
    Moy LY; Wang SP; Sonsalla PK
    J Pharmacol Exp Ther; 2007 Feb; 320(2):747-56. PubMed ID: 17090704
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Partial dopamine loss enhances activated caspase-3 activity: differential outcomes in striatal projection systems.
    Ariano MA; Grissell AE; Littlejohn FC; Buchanan TM; Elsworth JD; Collier TJ; Steece-Collier K
    J Neurosci Res; 2005 Nov; 82(3):387-96. PubMed ID: 16180225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protective effects of ginseng saponins on 3-nitropropionic acid-induced striatal degeneration in rats.
    Kim JH; Kim S; Yoon IS; Lee JH; Jang BJ; Jeong SM; Lee JH; Lee BH; Han JS; Oh S; Kim HC; Park TK; Rhim H; Nah SY
    Neuropharmacology; 2005 Apr; 48(5):743-56. PubMed ID: 15814108
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroprotective effect of L-carnitine in the 3-nitropropionic acid (3-NPA)-evoked neurotoxicity in rats.
    Binienda Z; Virmani A; Przybyla-Zawislak B; Schmued L
    Neurosci Lett; 2004 Sep; 367(2):264-7. PubMed ID: 15331167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dopamine modulates the susceptibility of striatal neurons to 3-nitropropionic acid in the rat model of Huntington's disease.
    Reynolds DS; Carter RJ; Morton AJ
    J Neurosci; 1998 Dec; 18(23):10116-27. PubMed ID: 9822765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurturin gene therapy improves motor function and prevents death of striatal neurons in a 3-nitropropionic acid rat model of Huntington's disease.
    Ramaswamy S; McBride JL; Herzog CD; Brandon E; Gasmi M; Bartus RT; Kordower JH
    Neurobiol Dis; 2007 May; 26(2):375-84. PubMed ID: 17336076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroprotective effect of nicotine against 3-nitropropionic acid (3-NP)-induced experimental Huntington's disease in rats.
    Tariq M; Khan HA; Elfaki I; Al Deeb S; Al Moutaery K
    Brain Res Bull; 2005 Sep; 67(1-2):161-8. PubMed ID: 16140176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IGF-1 exacerbates the neurotoxicity of the mitochondrial inhibitor 3NP in rats.
    Escartin C; Boyer F; Bemelmans AP; Hantraye P; Brouillet E
    Neurosci Lett; 2007 Oct; 425(3):167-72. PubMed ID: 17868993
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cannabidiol reduced the striatal atrophy caused 3-nitropropionic acid in vivo by mechanisms independent of the activation of cannabinoid, vanilloid TRPV1 and adenosine A2A receptors.
    Sagredo O; Ramos JA; Decio A; Mechoulam R; Fernández-Ruiz J
    Eur J Neurosci; 2007 Aug; 26(4):843-51. PubMed ID: 17672854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 3-Nitropropionic acid toxicity in hippocampus: protection through N-methyl-D-aspartate receptor antagonism.
    Karanian DA; Baude AS; Brown QB; Parsons CG; Bahr BA
    Hippocampus; 2006; 16(10):834-42. PubMed ID: 16897723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Minocycline fails to protect cerebellar granular cell cultures against malonate-induced cell death.
    Fernandez-Gomez FJ; Gomez-Lazaro M; Pastor D; Calvo S; Aguirre N; Galindo MF; Jordán J
    Neurobiol Dis; 2005 Nov; 20(2):384-91. PubMed ID: 16242643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serial 1H-NMR spectroscopy study of metabolic impairment in primates chronically treated with the succinate dehydrogenase inhibitor 3-nitropropionic acid.
    Dautry C; Condé F; Brouillet E; Mittoux V; Beal MF; Bloch G; Hantraye P
    Neurobiol Dis; 1999 Aug; 6(4):259-68. PubMed ID: 10448053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanism of 3-nitropropionic acid-induced membrane permeability transition of isolated mitochondria and its suppression by L-carnitine.
    Nishimura M; Okimura Y; Fujita H; Yano H; Lee J; Suzaki E; Inoue M; Utsumi K; Sasaki J
    Cell Biochem Funct; 2008 Dec; 26(8):881-91. PubMed ID: 18942062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A bile acid protects against motor and cognitive deficits and reduces striatal degeneration in the 3-nitropropionic acid model of Huntington's disease.
    Keene CD; Rodrigues CM; Eich T; Linehan-Stieers C; Abt A; Kren BT; Steer CJ; Low WC
    Exp Neurol; 2001 Oct; 171(2):351-60. PubMed ID: 11573988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 3-Nitropropionic acid neurotoxicity in organotypic striatal and corticostriatal slice cultures is dependent on glucose and glutamate.
    Storgaard J; Kornblit BT; Zimmer J; Gramsbergen JB
    Exp Neurol; 2000 Jul; 164(1):227-35. PubMed ID: 10877933
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of adenosine receptor agonists on neurodegenerative and convulsive activity of mitochondrial toxin, 3-nitropropionic acid.
    Zuchora B; Urbańska EM
    Pol J Pharmacol; 2001; 53(1):69-71. PubMed ID: 11785916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.